RTI Surgical® to Present at the JMP Securities Life Sciences Conference

DEERFIELD, Ill., June 05, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced that Camille Farhat, President and Chief Executive Officer, and Jonathon Singer, Chief Financial and Administrative Officer, are scheduled to present at the JMP Securities Life Sciences Conference on Wednesday, June 19, 2019, at the St. Regis New York at 3:30 p.m. EDT.

A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at http://www.rtix.com/en_us/investors/news-events. A replay of the webcast will be archived on the website for approximately 90 days.

Molly Poarch Media and Investor Contact [email protected] +1 224 287 2661

About RTI Surgical Holdings, Inc.

RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, plastic surgery, spine, orthopedic and trauma procedures and are distributed in more than 50 countries. RTI has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com. Connect with us on LinkedIn and Twitter.

You May Also Be Interested In

• Faraday Future Advances Its “Built in USA” Strategy, Participates in the FCC’s Public-Comment Process, and Signs a U.S. Compliance and Localization Advisory Agreement with AIBOT
• British Property Entrepreneur Samuel Leeds Takes The Eviction Competition to the US for the First Texas Series
• Cogent Communications Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Cogent Communications Holdings, Inc.